Paclitaxel-Containing Devices Linked to Improved Survival at 2 Years
Researchers assessed the safety and efficacy of paclitaxel (PTX) devices for treating peripheral artery disease involving the femoropopliteal artery.
Peripheral Artery Disease
Younger Adults Admitted for Peripheral Vascular Disease With CV Comorbidities
Using 2 national cohorts 10 years apart, researchers compared the mean age of young adults, who were hospitalized for PVD with CV comorbidities and major adverse cardiac and cerebrovascular events.
PAD With Elevated ABI an Independent Risk Factor for Heart Failure
Researchers sought to determine if peripheral artery disease is an independent risk factor for heart failure.
High Remnant Cholesterol Linked to 5-Fold Increased Risk for PAD
Researchers aimed to determine if remnant cholesterol was associated with increased risk for peripheral artery disease.
Smoking Before Revascularization Raises Complication Risks
Researchers sought to assess whether smoking before open and endovascular revascularization for intermittent claudication increased risk for postprocedural complications.
Varenicline Combination, Extension No Better for Quitting Smoking
Combining varenicline with nicotine patch, extending treatment from 12 to 24 weeks did not increase smoking cessation rates
Higher-Dose Statins Reduced All-Cause Mortality, Amputation Risk in PAD
Higher doses of statins may more effectively prevent adverse clinical outcomes in PAD.
Rivaroxaban and Aspirin Dual Therapy for Peripheral Artery Disease
A meta-analysis of COMPASS and VOYAGER compared low-dose rivaroxaban and aspirin vs aspirin alone across a broad spectrum of patients with PAD.
Peripheral Artery Disease Associated With Increased Abdominal Aortic Aneurysm Risk
A prospective, cross-sectional study examined the relationship between symptomatic and asymptomatic PAD with risk for abdominal aortic aneurysm.
Hybrid First-Line Treatment Approach for Chronic Limb-Threatening Ischemia
Investigators evaluated outcomes of a first-line hybrid approach in patients with chronic limb-threatening ischemia to determine possible predictors of loss of primary patency and limb clinical improvement.
- Loading...
Loading...
Next post in Vascular Medicine
Loading... 
Loading...